Consensus DexCom, Inc.

Equities

DXCM

US2521311074

Real-time Estimate Cboe BZX Other stock markets 09:46:41 2024-04-23 am EDT			5-day change	1st Jan Change
133.4 ^USD	+1.44%		-3.70%	+5.95%

Apr. 16	Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing	MT
Apr. 15	BTIG Adjusts DexCom's Price Target to $156 From $150	MT

Evolution of the average Target Price on DexCom, Inc.

Price target over the last 5 years

History of analyst recommendation changes

aafa5cab9d867d146872a6addf.2RPYNgfcsMDQoKRjOYHns9h6BRpXV6M5ZK-1ywRnjFY.kXSvb2ib0_i474kAStughbZJX1QZBZB1M8iGnmFe1AmccJpHVI_qluLp4Q~85a44ba852e7a395831194493b876476

Analyst Recommendations on DexCom, Inc.

Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing	Apr. 16	MT
BTIG Adjusts DexCom's Price Target to $156 From $150	Apr. 15	MT
UBS Raises DexCom's Price Target to $163 From $153, Maintains Buy Rating	Apr. 10	MT
Citigroup Raises Price Target on DexCom to $161 From $148, Keeps Buy Rating	Apr. 03	MT
DexCom Initiated at Outperform by RBC, Price Target Set at $165 on View for Revenue Upside Amid Rapidly Expanding Market	Mar. 12	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
UBS Adjusts DexCom Price Target to $153 From $149, Maintains Buy Rating	Feb. 09	MT
This time it's for real	Feb. 09
Bernstein Adjusts DexCom Price Target to $150 From $135, Maintains Outperform Rating	Feb. 09	MT
Leerink Partners Adjusts DexCom Price Target to $142 From $144, Maintains Outperform Rating	Feb. 09	MT
TD Cowen Adjusts DexCom Price Target to $160 From $110, Maintains Outperform Rating	Feb. 09	MT
Canaccord Genuity Adjusts DexCom Price Target to $144 From $137, Maintains Buy Rating	Feb. 09	MT
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber...	Feb. 09
Raymond James Raises DexCom Price Target to $151 From $147, Maintains Strong Buy Rating	Jan. 23	MT
UBS Adjusts DexCom Price Target to $149 From $145, Maintains Buy Rating	Jan. 22	MT
Raymond James Raises Price Target on DexCom to $147 From $131, Maintains Strong Buy Rating	Jan. 03	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments...	Dec. 21
Piper Sandler Adjusts DexCom Price Target to $150 From $135, Maintains Overweight Rating	Dec. 19	MT
Wells Fargo Increases Price Target on DexCom to $136 From $110, Maintains Overweight Rating	Dec. 13	MT
Morgan Stanley Raises DexCom's Price Target to $122 From $101, Maintains Equalweight Rating	Dec. 04	MT
Big tech saves the day	Nov. 13
ANALYST RECOMMENDATIONS : Airbnb, Apple, Best Buy, Diageo, Tesla...	Nov. 13
UBS Raises DexCom Price Target to $145 From $138, Maintains Buy Rating	23-10-27	MT
Piper Sandler Cuts Price Target on DexCom to $135 From $160, Maintains Overweight Rating	23-10-27	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

131.5 USD

Average target price

149.3 USD

Spread / Average Target

+13.51%

High Price Target

170 USD

Spread / Highest target

+29.26%

Low Price Target

105 USD

Spread / Lowest Target

-20.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DexCom, Inc.

BTIG
UBS
Citigroup
RBC Capital Markets
TD Cowen
Canaccord Genuity
Leerink Partners
Bernstein
Raymond James
Piper Sandler
Wells Fargo Securities
Morgan Stanley
Oppenheimer
BofA Securities
Stifel Nicolaus
Baird
Barclays
Cowen
Wolfe Research
JPMorgan Chase
Jefferies & Co.
SVB Leerink
Haywood Securities
Berenberg Bank
Guggenheim
Atlantic Equities

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar